Form 4: Hims & Hers Executive Deborah Autor Exercises RSUs

Chief Policy Officer Deborah M. Autor acquired 3,656 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.

Summary

• Deborah M. Autor, Chief Policy Officer at Hims & Hers Health, Inc., exercised 3,656 restricted stock units (RSUs).
• The transaction resulted in the acquisition of 3,656 shares of Class A Common Stock.
• Following the transaction, the reporting person holds a total of 31,438 shares of Class A Common Stock.
• The RSUs vested pursuant to the terms of the grant, which stipulated vesting on the earlier of the 2026 annual meeting or June 15, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding executive equity compensation.

Positives

• The transaction reflects the fulfillment of equity-based compensation, aligning executive interests with shareholder value.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership and potential future volatility in HIMS stock price.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of executive equity compensation, which is standard practice for publicly traded companies in the telehealth and consumer health sector.

Comparison to Industry Standards

• The transaction is consistent with standard executive compensation practices observed in the digital health industry, such as those seen at Teladoc or Ro.
• The vesting schedule aligns with typical corporate governance standards for equity incentive plans.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity vesting event.

Next Steps

• None mentioned.

Key Dates

Keywords

HIMS, Hims & Hers Health, Insider Transaction, Form 4, Restricted Stock Units, Equity Compensation